The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...
For GSK’s Ramakrishnan, who has served as CDTO since 2021, the biggest challenge was helping her company get a head start in ...
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
GSK PLC closed 18.56% short of its 52-week high of £18.24, which the company achieved on May 16th.
The FDA approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new ...
Shares of GSK PLC GSK slipped 1.73% to £15.05 Wednesday, on what proved to be an all-around positive trading session for the ...
10h
GlobalData on MSNGSK and UK researchers plan to study Shingrix and dementia risk reduction linkThe study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).
NEW YORK, NY / ACCESS Newswire / March 19, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers ...
19h
GlobalData on MSNEMA to review GSK’s Nucala for COPD treatment expansionGSK’s application is underpinned by the positive outcomes from the Phase III MATINEE trial, which demonstrated a significant ...
The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...
The approval was based on data from two late-stage trials showing the drug was superior to nitrofurantoin, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results